National Center for Integrative Biomedical Informatics

Consumer Health Tech Company AHARA Announces $10M+ Seed Round and Beta Launch

Retrieved on: 
Tuesday, June 6, 2023
Heart, Food, Nutrition, Genetics, Ageing, Nutrient, Medicine, Brain, Nutrition and Health, Premium, Biomarker, National Center for Integrative Biomedical Informatics, Assistant, Science, CDC, Greycroft, Tufts Medical Center, Entrepreneurship, National Board of Physician Nutrition Specialists, LOS, The RealReal, Health, Nursing, Pharmaceutical industry, Medical device, MD, GMV

LOS ANGELES, June 6, 2023 /PRNewswire/ -- AHARA, the only food-first personalized nutrition solution that translates clinically validated science into practical nutrition recommendations for optimal health, announces its beta launch with $10.25M in funding led by Greycroft with participation from Headline, SHAKTI, Dr. Samuel Jampolis, Co-founder Wainwright, and Sandy Sholl.

Key Points: 
  • AHARA, a Sanskrit word referring to nourishment, was conceived by well-known physician nutritionist Dr. Melina Jampolis and serial tech entrepreneur Julie Wainwright.
  • The co-founders bring deep experience in medicine and consumer technology and are now at the forefront of the rapidly evolving field of precision nutrition and health tech.
  • AHARA leverages the power of multiple data inputs from a scientifically developed health questionnaire, as well as genetic, epigenetic and biomarker testing.
  • I approached Dr. Melina with the idea for a health tech business that would reach millions, and she quickly understood that together we could help everyone achieve optimal health."

Global Diabetic Retinopathy Market Report to 2027 - Featuring Bayer, Alimera Sciences, Novartis and Pfizer Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 22, 2022
Health, Pharmaceutical, Prevalence, Blood, Diabetic retinopathy, Macular edema, Investment, Membrane, Severe cognitive impairment, Retina, Glaucoma, Retinal detachment, United Nations, National Center for Integrative Biomedical Informatics, Laser, Ageing, Insulin, Diabetes, National Center for Biotechnology Information, Housing, Retinal vessel analysis, Megasphaera, Transport, Eye, Developing country, Patient, Medical device, Pharmaceutical industry, Health insurance, Healthcare

The Global Diabetic Retinopathy Market size is expected to reach $7.7 billion by 2027, rising at a market growth of 11.3% CAGR during the forecast period.

Key Points: 
  • The Global Diabetic Retinopathy Market size is expected to reach $7.7 billion by 2027, rising at a market growth of 11.3% CAGR during the forecast period.
  • Impairment to blood vessels of the light-sensitive tissue of the retina is the main cause of diabetic retinopathy.
  • Diabetic retinopathy can also mutate to proliferative diabetic retinopathy, which is a more severe form of the disorder.
  • Non-proliferative diabetic retinopathy, NPDR, is a kind of diabetic retinopathy in which symptoms are minimal or absent.

The Worldwide Diabetic Retinopathy Industry is Expected to Reach $7.7 Billion by 2027 at a 11.3% CAGR

Retrieved on: 
Tuesday, November 22, 2022
Glaucoma, National Center for Biotechnology Information, Macular edema, Diabetic retinopathy, Infection, COVID-19, Severe cognitive impairment, Developing country, Megasphaera, Housing, National Center for Integrative Biomedical Informatics, Retina, Health, Oxygen, Eye, Diabetes, Ageing, Insulin, Investment, Patient, Failure, Blood, Laser, Retinal vessel analysis, Hospital, Bed, Membrane, Prevalence, United Nations, Retinal detachment, Transport, Medical device, Pharmaceutical industry, Health insurance

The Global Diabetic Retinopathy Market size is expected to reach $7.7 billion by 2027, rising at a market growth of 11.3% CAGR during the forecast period.

Key Points: 
  • The Global Diabetic Retinopathy Market size is expected to reach $7.7 billion by 2027, rising at a market growth of 11.3% CAGR during the forecast period.
  • Diabetic retinopathy can progress to diabetic retinal detachment, macular edema, and neovascular glaucoma, among other serious eye disorders.
  • Diabetic retinopathy can also mutate to proliferative diabetic retinopathy, which is a more severe form of the disorder.
  • Non-proliferative diabetic retinopathy, NPDR, is a kind of diabetic retinopathy in which symptoms are minimal or absent.

Genetic Testing Global Market Research Report 2022 Featuring Major Players - Abbott Laboratories, Bio-Rad Laboratories, Eurofins Scientific, F. Hoffmann-La Roche, & Illumina - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 11, 2022
Health, Genetics, Lists of diseases, Genetics, Sale, Risk, Anti-transglutaminase antibodies, Prevalence, Growth, Diagnosis, Asia-Pacific, Organization, Genetic testing, Patient, National Center for Biotechnology Information, Exact sciences, Thalassemia, Cancer, Cystic fibrosis, Degenerative disease, Genetic disorder, Technology, Duchenne muscular dystrophy, Acquisition, National Center for Integrative Biomedical Informatics, Alzheimer's disease, Protein, Huntington's disease, DNA, Chromosome, COVID-19, Gene, Vaccine

The main types of genetic testing are predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, nutrigenomic testing, and other types.

Key Points: 
  • The main types of genetic testing are predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, nutrigenomic testing, and other types.
  • The rising prevalence of genetic disorders is expected to propel the growth of the genetic testing market going forward.
  • Major companies operating in the genetic testing market are focused on developing technology to sustain their position in the market.
  • The countries covered in the genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology

Retrieved on: 
Tuesday, November 9, 2021
Quality of life, Mortality, ADA, Health education, American Diabetes Association, Healthcare disparity in Massachusetts, Color, Health, Ohio State University, Education, Health Resources and Services Administration, Technology, Diabetes, Research, Program, Partnership, Endocrinology, Awareness, Metabolism, Solution, Glucose, LinkedIn, Continuous glucose monitor, Prenatal nutrition, National Center for Integrative Biomedical Informatics, Connected for Life, NYSE, Time, FreeStyle, Life, Risk, Health equity, Pharmaceutical industry, Medical device

ABBOTT PARK, Ill. and ARLINGTON, Va., Nov. 9, 2021 /PRNewswire/ --Abbott (NYSE: ABT) and the American Diabetes Association (ADA) announced today the launch of their first joint community health partnership.

Key Points: 
  • ABBOTT PARK, Ill. and ARLINGTON, Va., Nov. 9, 2021 /PRNewswire/ --Abbott (NYSE: ABT) and the American Diabetes Association (ADA) announced today the launch of their first joint community health partnership.
  • The program seeks to better understand and address healthcare disparities for people of color living with diabetes, while fostering accessibility of diabetes care technology within the community.
  • "Diabetes is one of the most pressing health issues of our time, particularly for people of color," said Charles Henderson, chief advocacy officer of the American Diabetes Association.
  • About the American Diabetes Association:
    The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive.

Michigan Governor Appoints Aunalytics CMO Katie Horvath to the Michigan Women’s Commission

Retrieved on: 
Tuesday, August 10, 2021
University, National Cancer Registrars Association, Industry, BSE, Caucus, Michigan Department of Civil Rights, CEO, Commission, LinkedIn, IOE, TM, Data science, JD, National Center for Integrative Biomedical Informatics, Industrial, Technology, FLOW, University of Michigan School of Information, Notre Dame, Workforce, Center for Automotive Research, Big data, Congress, Twitter, Munson Medical Center, Board, Daybreak, Woman, Microsoft, Advisory board, Center, GLOBE, IP, Horváth, AI, Commodore, Pharmaceutical industry

SOUTH BEND, Ind., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Aunalytics , a leading data platform company delivering Insights-as-a-Service for enterprise businesses, announced that the companys Chief Marketing Officer Katie Horvath has been appointed by Michigan Governor Gretchen Whitmer to the Michigan Womens Commission .

Key Points: 
  • SOUTH BEND, Ind., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Aunalytics , a leading data platform company delivering Insights-as-a-Service for enterprise businesses, announced that the companys Chief Marketing Officer Katie Horvath has been appointed by Michigan Governor Gretchen Whitmer to the Michigan Womens Commission .
  • The 15-member Michigan Women's Commission is responsible for reviewing the status of women in Michigan, directing attention to critical problems confronting women, and recognizing women's accomplishments and contributions to the state.
  • It is an honor to have been chosen to serve on the Michigan Womens Commission, which plays an instrumental role in helping women thrive in our state, said Horvath.
  • Horvath joined Aunalytics when Naveego, the data integration platform company that she led as President and CEO was acquired by Aunalytics.